We are happy to announce that our long-term client and trusted partner, Greene Street Pharmaceuticals LLC, strengthened our business relationship today by appointing us as their exclusive API sourcing partner.

The Pennsylvania-based company specializes in #transdermal delivery systems with the vision to make a meaningful impact on patients’ lives. Greene Street utilizes Quinta-Analytica’s API Solution services for multiple projects and is able to leverage the partnership to ensure a high level of continuity and expand their offering beyond the scope of their core service provision.

This is yet another recognition of Quinta’s world-class API Solutions program, which supports partners from all geographies and backgrounds with our robust services – now and into the future!

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.